Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsAlessandra Fabi, Laura Iacorossi, Sabrina Vari et al.|Drug Design Development and Therapy|2015Cited by 29
Phase I of weekly nab-paclitaxel in combination with weekly liposomal encapsulated doxorubicin as first-line treatment for HER2 negative metastatic breast cancer patients: preliminary resultsAlessandra Fabi, Francesco Cognetti, Paola Malaguti et al.|Annals of Oncology|2015Cited by 0